Trials / Completed
CompletedNCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,133 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Detailed description
Subjects who have been diagnosed, or who have a suspicion of diagnosis based on imaging, with any solid tumor. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.
Conditions
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Uterine Cancer
- Kidney Cancer
- Renal Pelvis Cancer
- Pancreatic Cancer
- Liver Cancer
- Stomach Cancer
- Ovarian Cancer
- Esophageal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sample Collection | Subjects participating in the study will have blood drawn at enrollment. |
Timeline
- Start date
- 2018-08-23
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2018-09-07
- Last updated
- 2022-09-01
Locations
119 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03662204. Inclusion in this directory is not an endorsement.